江苏恒瑞医药股份有限公司关于召开2025年半年度业绩说明会的公告

Core Viewpoint - Jiangsu Hengrui Medicine Co., Ltd. is set to hold a half-year performance briefing for 2025 to provide investors with insights into its operational results and financial status [3][4]. Group 1: Meeting Details - The performance briefing will take place on September 1, 2025, from 13:00 to 14:00 [5][7]. - The meeting will be conducted in an interactive online format via the Shanghai Stock Exchange Roadshow Center [4][7]. - Key personnel attending the meeting include the company's president, independent directors, financial director, and board secretary [5]. Group 2: Investor Participation - Investors can participate in the meeting by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [6]. - A pre-collection of questions from investors will be open from August 25 to August 29, 2025, allowing them to submit inquiries via the Roadshow Center or the company's email [6][8]. - The company will address commonly raised questions during the briefing [3][6].